Early Bird Deadline Is Tonight
Don't Miss Out: Probiota 2020 early bird tickets end today!
Probiota 2020 will combine the latest insights from science, regulation and business to provide delegates with the ultimate event to bridge the gap between the worlds of business and primary research.
Moving from a sell-out event with more than 400 people in the room for our 2019 Copenhagen edition, the event is set to relocate to Ireland for its next instalment as the congress continues to explore the frontiers of prebiotic, probiotic and microbiome science, and how that is applied in the commercial world for food, pharma and nutraceutical players everywhere.
Top academics and business leaders from Europe, the USA and Asia will address the wold-leading conference, to be held in Dublin between 10 and 12 February 202.
Early bird registration for this industry-leading event ends today (Friday 27th September).
Register now to receive a significant discount on both industry and academic delegate places!
The annual event will bring together experts and leaders from global industries and academia together in one place to present top-level insights and provide otherwise impossible networking opportunities.
Check out the highlights from out sold-out 2019 edition of Probiota - held in Copenhagen.
Key themes announced!
On the agenda at Probiota 2020 are engaging sessions tackling the multitude of microbiome modulators and their mechanisms of action. From probiotics and prebiotics to FMT, bacterial phages and other microbiome therapy approaches, Probiota 2020 sessions will dig deep into the scientific frontiers of human microbiome research as we focus on the convergence of food and pharmaceutical industries in the microbiome space.
Don’t miss sessions on the potential applications of next-gen probiotics, a fresh look at the scientific frontiers and commercial applications of targeting the gut-brain axis, the importance of good clinical trial design in microbiome research, and a look at the growing interest around beauty from within and the skin microbiome.
In addition, we will take an in depth look at regulations and health claims – focusing particularly on how to retain credibility in the growing mass-market in a claimless environment and how the industry can better deal with fake claims – plus the rapidly developing conversations around QC and finished product standards, and tackling challenges in the formulation, production and upscaling of microbiome-targeting products.
Don’t miss key updates from the IPA, alongside, pitches and presentations from the latest microbiome start-up pioneers and engaging discussions on how to better engage with and educate consumers and medical professionals.
The early advance programme is now available to download, and we are pleased to announce the above key themes and following topics as key focus areas for the 2020 edition of Probiota:
- Understanding the mechanisms of action of microbiome modulators
- New research and commercial applications from the gut-brain axis
- The convergence of food and pharma in the microbiome space
- Next-gen probiotics: Who, what & why?
- Clinical trials in the microbiome: A need for better design and guidelines?
- The skin microbiome: A new frontier?
- Retaining credibility and fighting fake claims in a crowded market
- Quality control and technical challenges of manufacturing
- A deep dive into the world of Bacterial phages
- Education of consumers and healthcare professionals
- E-commerce and cross-border trade
- Probiotic innovation: The next big thing?
- Mass market appeal: From supplements to food and drinks
- Weight management: Old hat or the next big thing?
- DNA testing and end-product quality control
- MyMicrobiome: The microbiome in personalised nutrition
- Fermented foods: Where now?
- Food service & out of home: New routes to market for innovative products?
